未登录

L

Llewellyn Mills

University of Sydney

H指数:14

被引数:718

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cannabis use disorder in patients prescribed medical cannabis—Should we consider prescription cannabis use disorder as a new diagnostic condition?

医用大麻使用障碍患者中的大麻使用障碍——我们是否应将处方大麻使用障碍视为一种新的诊断条件？

IF5.3

2026-08-290

OAAI

Medical cannabis and driving in Australia: Results from the cannabis as medicine survey 2022–2023 (CAMS-22)

医疗大麻与驾驶：2022–2023年大麻作为药物调查（CAMS-22）结果

transportation research part f: traffic psychology and behaviour

IF0

2026-01-060

OAAI

Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in Australia

澳大利亚消费者对从大麻诊所与综合医疗机构获取药用大麻治疗的看法

Journal of Cannabis Research

IF4.3

2025-10-280

OAAI

Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment

临床医生对接受阿片类药物依赖治疗客户的 Cannabis 使用和 Cannabis 治疗的看法

DRUG AND ALCOHOL REVIEW

IF2.6

2025-05-050

OA

Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia

澳大利亚新南威尔士州寻求酒精治疗人群的社会人口统计学和健康因素

JOURNAL OF ADDICTION MEDICINE

IF3.2

2024-06-030

PRE

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)

HARM REDUCTION JOURNAL

IF4

2024-05-283

OAAI

The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational study

BMC PUBLIC HEALTH

IF3.6

2024-02-020

OAAI

Trajectories of Psychological Distress of Men Treated at Aboriginal Residential Rehabilitation Services for Alcohol and Drug Misuse

INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION

IF2.5

2023-12-200

PRE

A systematic review on the effect of routine outcome monitoring and feedback on client outcomes in alcohol and other drug treatment

DRUG AND ALCOHOL REVIEW

IF2.6

2023-08-314

OA

Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study

MEDICAL JOURNAL OF AUSTRALIA

IF8.5

2023-07-142

OA

Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile

IF5.3

2023-07-082

OA

Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey

NATURE AND SCIENCE OF SLEEP

IF3.4

2023-04-013

OAAI

Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019

DRUG AND ALCOHOL REVIEW

IF2.6

2022-12-162

OAAI

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY

IF3.2

2022-10-084

OAAI

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

HARM REDUCTION JOURNAL

IF4

2022-07-3031

OAAI

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2022-05-012

PRE

The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions

DRUG AND ALCOHOL REVIEW

IF2.6

2022-04-205

OAAI

Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

DRUG AND ALCOHOL REVIEW

IF2.6

2022-02-1619

OA

Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia

DRUG AND ALCOHOL REVIEW

IF2.6

2021-09-1430

OA

Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions

DRUG AND ALCOHOL REVIEW

IF2.6

2021-06-296

PREAI